BC
BHVN
Birchview Capital’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,365
| Closed | -$275K | – | 72 |
|
|
2024
Q4 | $275K | Hold |
7,365
| – | – | 0.22% | 51 |
|
|
2024
Q3 | $368K | Hold |
7,365
| – | – | 0.32% | 39 |
|
|
2024
Q2 | $256K | Hold |
7,365
| – | – | 0.24% | 46 |
|
|
2024
Q1 | $403K | Hold |
7,365
| – | – | 0.33% | 41 |
|
|
2023
Q4 | $315K | Buy |
+7,365
| New | +$315K | 0.25% | 42 |
|
|
2023
Q1 | – | Sell |
-7,365
| Closed | -$102K | – | 60 |
|
|
2022
Q4 | $102K | Sell |
7,365
-7,365
| -50% | -$102K | 0.07% | 53 |
|
|
2022
Q3 | $2.23M | Sell |
14,730
-270
| -2% | -$40.8K | 1.57% | 14 |
|
|
2022
Q2 | $2.19M | Buy |
15,000
+1,000
| +7% | +$146K | 1.59% | 14 |
|
|
2022
Q1 | $1.66M | Buy |
14,000
+2,000
| +17% | +$237K | 1.2% | 15 |
|
|
2021
Q4 | $1.65M | Buy |
12,000
+2,000
| +20% | +$276K | 1.07% | 17 |
|
|
2021
Q3 | $1.39M | Hold |
10,000
| – | – | 0.95% | 20 |
|
|
2021
Q2 | $971K | Hold |
10,000
| – | – | 0.58% | 31 |
|
|
2021
Q1 | $684K | Hold |
10,000
| – | – | 0.41% | 37 |
|
|
2020
Q4 | $857K | Hold |
10,000
| – | – | 0.49% | 31 |
|
|
2020
Q3 | $650K | Hold |
10,000
| – | – | 0.43% | 29 |
|
|
2020
Q2 | $731K | Hold |
10,000
| – | – | 0.44% | 31 |
|
|
2020
Q1 | $340K | Hold |
10,000
| – | – | 0.3% | 35 |
|
|
2019
Q4 | $544K | Buy |
+10,000
| New | +$544K | 0.4% | 33 |
|